Talphera Inc. (TLPH)
TLPH trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.07
-0.93% on the day
Market cap
$55.5M
Micro cap
Revenue · 2025
$28K
No prior year to compare
Net income · 2025
-$14.3M
-51035.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1427925/000143774926009387/0001437749-26-009387-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | TLPH on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2011 |
| SEC CIK | 0001427925 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $28K |
| Net income | -$14.3M |
| Operating income | -$13.5M |
| Net margin | -51035.7% |
| Operating margin | -48157.1% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $5.9M |
| Total assets | $29.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1983.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B7 | 424B7 | 2026-04-01 |
| Latest annual report FORM 10-K | 10-K | 2026-03-23 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-12 |
| Latest current report FORM 8-K | 8-K | 2026-08-12 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 962 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BOLD | Boundless Bio Inc. | $2.43 | -4.71% | $56.2M |
| ALDX | Aldeyra Therapeutics Inc. | $0.8998 | -0.66% | $54.3M |
| CNTB | Connect Biopharma Holdings Limited | $0.9188 | +1.45% | $57.9M |
| RNXT | RenovoRx Inc. | $1.15 | -8.00% | $51.9M |
| ATHE | Alterity Therapeutics Limited | $2.85 | -2.73% | $51.9M |
| HYPD | Hyperion DeFi Inc. | $3.36 | -3.17% | $51.9M |
| GOSS | Gossamer Bio Inc. | $9.76 | +5.17% | $59.7M |
| TENX | Tenax Therapeutics Inc. | $1.60 | -12.57% | $59.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier